The Danger of Prior Authorization for Rare Cancer Patients
2022 Amyloidosis Initiative Meeting Summary
Patient-Centered Care: A Position Statement
Urgent Action Paused by Prior Authorization
There’s no ‘Moonshot’ or ‘Warp Speed’ for rare diseases. There should be
Accelerated Approval Prioritizes Patients’ Access to Promising Treatments
The Cardiovascular Health Policy Summit in Five Quotes
Game-Changing Medication Brightens Outlook for Vision Patients
New Medication Offers New Hope for Heart Patients
Alzheimer’s Patients Dealt a Devastating Blow
